Overview
Legionnaires disease (also known as Legionellosis or Legion fever) is a severe form of pneumonia caused by infection with Legionella bacteria, most commonly Legionella pneumophila. It is not a genetic disorder but rather an infectious disease classified among rare conditions due to its relatively uncommon occurrence. The bacteria are typically found in freshwater environments and can proliferate in man-made water systems such as cooling towers, hot tubs, decorative fountains, and large plumbing systems. Humans become infected by inhaling aerosolized water droplets or mist contaminated with the bacteria; person-to-person transmission does not occur. The disease primarily affects the respiratory system, causing a serious and potentially life-threatening pneumonia. Key clinical features include high fever (often exceeding 40°C/104°F), chills, cough (which may be productive or dry), shortness of breath, muscle aches (myalgia), headaches, and gastrointestinal symptoms such as diarrhea, nausea, and vomiting. Neurological manifestations including confusion and altered mental status may also occur. The disease can progress to respiratory failure and multi-organ dysfunction, particularly affecting the kidneys and liver. Certain populations are at higher risk, including older adults (typically over 50 years), current or former smokers, individuals with chronic lung disease, and immunocompromised persons, including those on immunosuppressive therapy or with conditions such as diabetes or cancer. Treatment consists of antibiotic therapy, with fluoroquinolones (such as levofloxacin or moxifloxacin) and macrolides (such as azithromycin) being the preferred agents. Early initiation of appropriate antibiotic therapy significantly improves outcomes. Hospitalization is frequently required, and severe cases may necessitate intensive care support including mechanical ventilation. Even with appropriate treatment, the case fatality rate can range from approximately 5% to 10% in community-acquired cases and may be higher in nosocomial (hospital-acquired) outbreaks or among immunocompromised patients. Prevention strategies focus on proper maintenance and disinfection of water systems to minimize bacterial colonization.
Clinical phenotype terms— hover any for plain English:
Adult
Begins in adulthood (age 18 or older)
Treatments
No FDA-approved treatments are currently listed for Legionnaires disease.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Legionnaires disease at this time.
New trials open frequently. Follow this disease to get notified.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Legionnaires disease.
Community
No community posts yet. Be the first to share your experience with Legionnaires disease.
Start the conversation →Latest news about Legionnaires disease
No recent news articles for Legionnaires disease.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Legionnaires disease
What is Legionnaires disease?
Legionnaires disease (also known as Legionellosis or Legion fever) is a severe form of pneumonia caused by infection with Legionella bacteria, most commonly Legionella pneumophila. It is not a genetic disorder but rather an infectious disease classified among rare conditions due to its relatively uncommon occurrence. The bacteria are typically found in freshwater environments and can proliferate in man-made water systems such as cooling towers, hot tubs, decorative fountains, and large plumbing systems. Humans become infected by inhaling aerosolized water droplets or mist contaminated with the
At what age does Legionnaires disease typically begin?
Typical onset of Legionnaires disease is adult. Age of onset can vary across affected individuals.
Which specialists treat Legionnaires disease?
19 specialists and care centers treating Legionnaires disease are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.